{"nctId":"NCT02910726","briefTitle":"A Study Comparing Green Fluorescent Dye and Radioactive Dye for Sentinel Lymph Node Biopsy in Pediatric Cancers","startDateStruct":{"date":"2016-09-13","type":"ACTUAL"},"conditions":["Pediatric Patients With Solid Tumors"],"count":6,"armGroups":[{"label":"Sentinel Lymph Node Biopsy","type":"EXPERIMENTAL","interventionNames":["Procedure: Sentinel Lymph Node Biopsy","Drug: indocyanine green (ICG)"]}],"interventions":[{"name":"Sentinel Lymph Node Biopsy","otherNames":[]},{"name":"indocyanine green (ICG)","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients \\<30 years old with an extracoelomic solid tumor, diagnosis confirmed at the enrolling institution, requiring SLN biopsy\n* Women of childbearing potential must have a negative pregnancy test (urine or blood) pre-operatively as per the standard hospital policy. A woman of childbearing potential is defined as one who is biologically capable of becoming pregnant.\n* Patients who are cleared for surgery\n\nExclusion Criteria:\n\n* History of reaction to ICG, iodides, or technetium radiocolloid\n* Intracoelomic primary tumors or tumors expected to drain to an intracoelomic SLN\n* Patients with extensive prior surgery at the primary site or nodal basin expected to affect the lymphatic drainage\n* Patients unwilling or unable to sign informed consent\n* Women who are pregnant or breast-feeding","healthyVolunteers":false,"sex":"ALL","maximumAge":"30 Years","stdAges":["CHILD","ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"% of Patients in Whom a Sentinel Lymph Node is Identified","description":"These percentages will be compared using a non-inferiority comparison for matched pair data.","classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":6},"commonTop":[]}}}